▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Scinai Immunotherapeutics (NASDAQ: BVXV)

$1.36

(-2.2%)

-$0.03

Price as of October 2, 2025, 3:59 p.m. ET

Scinai Immunotherapeutics Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
BVXV	-60.17%	-99.96%	-79.61%	-100%
S&P	+17.56%	+100.43%	+14.92%	+220%

Scinai Immunotherapeutics Company Info

BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.

News & Analysis

Featured Article

Why BiondVax Pharmaceuticals Stock Imploded Today

The company reported negative results from a pivotal clinical trial.

Prosper Junior Bakiny | Oct 23, 2020

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services